How to Spot Fake Mounjaro or Zepbound

Tirzepatide is the active ingredient in two Eli Lilly products. In the United States, Mounjaro is approved for type 2 diabetes and Zepbound is approved for weight management and for obstructive sleep apnea in adults with obesity. Those two brands are the only FDA-approved tirzepatide medicines sold in this country [1].

Everything else that carries the name — the pens on a marketplace app, the vials from an offshore website, the powder in a bag labeled “research use only,” the “Mounjaro” a med-spa says it can get you — falls somewhere between unapproved and outright counterfeit. Lilly says flatly that it does not supply tirzepatide to compounding pharmacies, med-spas, wellness centers or online retailers, and that it does not know where other sellers are getting the active ingredient they use [1].

This guide walks through what a genuine pen looks like, what investigators have actually found inside fakes, and the checks you can run before anything goes into your body. It is not medical advice, and it will not tell you what to take. Those conversations belong with a licensed healthcare provider.

What does a real Mounjaro or Zepbound pen look like?

Lilly publishes photos of authentic pens and names the specific design features it has registered as trademarks. According to the company’s open letter [1]:

Mounjaro

• A purple injection button
• The Mounjaro federally registered trademark
• A tri-lobular (three-lobed) base cap in a distinctive shade of gray, which is itself trademarked
• The script Lilly logo in black ink

Zepbound

• A purple injection button
• The Zepbound federally registered trademark
• The same tri-lobular gray base cap
• The script Lilly logo in red ink

That black-versus-red logo distinction is the single most useful detail most people have never heard. It is also the kind of thing a counterfeiter working from a photo gets wrong.

A genuine package also arrives with the Instructions for Use and the Medication Guide. Lilly’s product information tells patients to read the Instructions for Use that come with the pen [1]. If a seller ships a bare pen in a padded envelope with no paperwork, that is not how a licensed U.S. pharmacy dispenses this product.

What have regulators and Lilly found inside fakes?

The contents are worse than most people assume. Lilly reports that products advertised as tirzepatide have been found to contain bacteria, high impurity levels, a different color than the genuine medicine — pink instead of colorless — or a completely different chemical structure. In at least one instance, the product was nothing more than sugar alcohol [1][2].

Counterfeits also show up in ordinary criminal cases. In December 2024, officials in West Tennessee seized more than 300 vials of counterfeit semaglutide and tirzepatide from a home in Medina; Lilly’s testing of one sample found only water [3].

Sellers also ship product disguised as something else. Fake Mounjaro cases outside the United States have turned on off-shade packaging and typographical errors, including a seizure in Gurugram, India in 2026 where investigators said the packaging and typos gave the operation away [4]. Those foreign cases involve the same brand name in a market where Mounjaro is also the weight-loss brand, so overseas coverage can read oddly to a U.S. audience — but the counterfeiting technique travels.

Even in the legal compounding world, contamination has been a live issue. In March 2026, Lilly said it had found an impurity in a compounded version of its weight-loss drug and warned of health risks [5]. FDA maintains a public page of compounding inspections, recalls and other actions where those events are recorded [6].

Does Lilly sell Mounjaro or Zepbound on social media?

No, and this is the cleanest single rule in the whole subject.

Lilly states: “Lilly never sells genuine Mounjaro or Zepbound on social media. Any Mounjaro or Zepbound offered for purchase on social media is unlawful. These products are either fake or being ‘resold’ by an individual who obtained them through some other means. Both practices put people at risk.” [1]

So an Instagram account, a Facebook group, a WhatsApp contact or a Telegram channel offering brand-name tirzepatide is, by the manufacturer’s own statement, offering something that is either counterfeit or diverted. There is no third possibility where it is a legitimate discount.

The National Association of Boards of Pharmacy has said illegal actors are exploiting high demand for these drugs to sell substandard and falsified versions, and that it has identified thousands of websites promoting illegal GLP-1 sales [1].

What are FDA’s warning signs?

FDA’s consumer page on unapproved GLP-1 drugs, updated September 1, 2026, lists the practical checks it wants people to run [7]:

• Get a prescription from a licensed healthcare provider
• Fill it at a state-licensed pharmacy
• Check the label for spelling errors and verify the pharmacy address
• Refuse product that arrives warm or without proper refrigeration
• Treat a price that seems too good to be true as a warning sign

FDA also runs BeSafeRx, a consumer program with a “Locate a State-Licensed Online Pharmacy” lookup so you can confirm a pharmacy is actually licensed before you order [8].

There is one more FDA warning that undercuts the most obvious check. The agency has documented fraudulently labeled compounded GLP-1 products sold in the United States: in some cases the compounding pharmacy named on the vial does not exist, and in others the label carries the name of a real licensed pharmacy that did not compound the product. FDA is aware of an adverse event report involving a product labeled as compounded tirzepatide from a pharmacy that had not made it, with redness, injection-site swelling, pain and a red lump [7][9].

In other words: reading the pharmacy name off a vial and finding that pharmacy in a license lookup is a reasonable step, but it can produce false reassurance. It confirms the name on the label exists. It does not confirm that the company made what is in your hand.

How does the price tell you something?

Counterfeiters compete on price, so knowing the legitimate floor is useful.

Lilly publishes self-pay prices through its own LillyDirect channel, filled by third-party pharmacies including Amazon Pharmacy, Fuze Health, Gifthealth and Walmart Pharmacy. As of September 2026 the published Zepbound self-pay ladder runs about $299 a month for 2.5 mg, $399 for 5 mg and $449 for 7.5 mg and higher (verified 2026-09-14), with the top tier tied to refilling within roughly 45 days. Mounjaro is a different matter. A flat $499 across strengths circulates widely, but we could not verify it on any Lilly page in September 2026, and the trail suggests a mix-up: Lilly did announce a flat $499 through LillyDirect in June 2025, for Zepbound single-dose vials, and that price was cut to the $299/$399/$449 ladder on December 1, 2025. A second live $499 is the Zepbound savings-card tier for commercially insured patients whose plan excludes the drug. Neither is a Mounjaro self-pay price, and for contrast Hims lists Mounjaro at $1,899 a month. Do not treat $499 as the Mounjaro cash price [10]. In March 2026, Lilly announced that self-pay pricing on the Zepbound KwikPen would also be available at major pharmacies nationwide starting at $299 a month, with a savings card open to uninsured patients [11].

Those figures move, so check them at the source before relying on them. But they establish the shape of the market: brand-name tirzepatide from the manufacturer, paid in cash, sits in the low hundreds of dollars a month. An offer of “real Zepbound” for $60 a month from an account with no pharmacy license is not a bargain. It is the warning sign FDA described.

Are pills, drops and nasal sprays ever real Mounjaro or Zepbound?

No. FDA has approved tirzepatide only for administration by injection under the skin. Lilly states that FDA has only approved administration of tirzepatide via under-the-skin injection, that no regulator has evaluated the safety or effectiveness of pill or other oral versions of “tirzepatide,” and that certain online pharmacies nonetheless advertise them [1][12]. Nasal and other non-injectable routes are likewise unapproved.

Several telehealth platforms and compounders have sold oral tirzepatide products under names like sublingual tablets, oral dissolving tablets and “drops.” The Connecticut Attorney General told weight-loss clinics and spas in a May 2025 letter that oral GLP-1 products made by compounding pharmacies have not been shown to deliver safe or effective doses [13].

A separate point worth keeping straight: Lilly does market an approved oral GLP-1 medicine, but it is orforglipron, a different molecule, not tirzepatide in pill form.

What about “research use only” tirzepatide powder?

There is a large gray market selling lyophilized peptide powder online, often under coded names, with disclaimers saying the product is for research purposes or not for human consumption. Buyers reconstitute it themselves.

Lilly’s position is blunt: those markings indicate the product has not been purified to pharmaceutical-grade levels and is not appropriate for human use [1]. FDA has issued warning letters to companies selling semaglutide, tirzepatide and related peptides under that labeling, treating the disclaimers as ineffective when the surrounding marketing signals human use — particularly when the seller also ships bacteriostatic water [7].

There is also a border-control angle that matters if you are ordering from abroad. After a Section 337 complaint Lilly filed with the U.S. International Trade Commission in October 2023 [14], the Commission issued a general exclusion order in April 2025 barring importation of products containing or purporting to contain tirzepatide that infringe Lilly’s trademark or carry a false designation of origin [15]. A general exclusion order applies to any importer, not only the companies named in the case. Product ordered from an overseas peptide site can be stopped at the border regardless of who shipped it.

What is the difference between a counterfeit and compounded tirzepatide?

These get blurred constantly, and the distinction matters.

Counterfeit means the product pretends to be the brand — fake Mounjaro or Zepbound packaging, trademarks, pens. It is illegal on its face.

Compounded tirzepatide is mixed by a pharmacy rather than manufactured by Lilly. It is not FDA-approved and has not been reviewed for safety, effectiveness or quality before sale, but compounding is lawful in narrow circumstances. Since FDA declared the tirzepatide shortage resolved and the wind-down periods closed in early 2025, the broad shortage-based pathway that built the compounded market is gone [16].

Fraudulently labeled compounded product is the hybrid FDA has flagged: real-looking vials naming pharmacies that did not make the contents [7].

All three can arrive in a padded envelope looking equally plausible. Only the first is defined by trademark infringement, which is why the legal fight and the safety fight do not map onto each other neatly.

What should you do if you think a product is fake?

FDA and Lilly give consistent instructions [1][7]:

1. Do not use it. Set it aside rather than injecting it.
2. Contact a healthcare provider, or seek immediate medical attention if you have already used it and feel unwell.
3. Report it. To FDA through MedWatch, to your state board of pharmacy, and to local law enforcement.
4. Call the Lilly Answers Center at 1-800-545-5979. Lilly says it can help direct you to a legitimate supply, explain its savings programs, and assist with reporting adverse events tied to counterfeit or unsafe tirzepatide.

Keep the packaging, the label, the shipping envelope and any order confirmation. Investigators and pharmacy boards work from lot numbers and seller details, and a discarded box ends an inquiry before it starts.

A short checklist you can actually use

• Buy only through a state-licensed pharmacy, verified in a license lookup, not a social media account [7][8]
• Remember that any brand-name tirzepatide sold on social media is unlawful by Lilly’s own statement [1]
• Compare the pen and carton against Lilly’s published images: purple button, tri-lobular gray base cap, script Lilly logo in black for Mounjaro and red for Zepbound [1]
• Look for blurry printing, off-shade color and misspellings, which is what broke real counterfeit cases [4][7]
• Check that the solution looks the way it did last time — clear and colorless, not pink or cloudy [1]
• Refuse packages that arrive warm, unsealed or damaged, or without the Instructions for Use and Medication Guide [7]
• Treat a price far below the manufacturer’s published self-pay price as a red flag, not a find [7][10]
• Be aware that a pharmacy name on a compounded vial can be false, so it is a weak check on its own [7][9]
• Confirm a licensed clinician reviewed your case and is reachable afterward
• Never use anything labeled “research use only” or “not for human consumption” [1]

The bottom line

Two products in the United States are genuine tirzepatide: Mounjaro for type 2 diabetes and Zepbound for weight management and obstructive sleep apnea. Everything sold outside a licensed pharmacy — and everything sold on social media — carries a real risk of being counterfeit, contaminated, mislabeled or empty.

The good news is that the checks are cheap. Look at the logo color. Look at the print quality. Look at the price against the manufacturer’s published price. Look up the pharmacy license. Any one of those failing is reason enough to stop and talk to a healthcare provider before using the product.

---

Sources

1. An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro and Zepbound (June 20, 2024)
2. Lilly Warns Patients About Counterfeit and Compounded Medicines (June 20, 2024)
3. Tennessee woman accused of selling fake weight loss drugs — NBC News
4. Different packaging, typos expose fake Mounjaro racket — The Economic Times
5. Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks — Reuters
6. Compounding: Inspections, Recalls, and other Actions — FDA
7. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — FDA
8. BeSafeRx: Your Source for Online Pharmacy Information — FDA
9. FDA GLP-1 import alert and fraudulent compounded labels — Medical Daily
10. Authentic Zepbound (tirzepatide) Shipped to You — LillyDirect
11. Media Statement: Zepbound KwikPen now available at self-pay pricing at major pharmacies nationwide — Eli Lilly
12. What are the health risks of using compounded tirzepatide? — Lilly Medical Information
13. Connecticut Attorney General letter to weight loss clinics and spas (May 21, 2025)
14. USITC Institutes Section 337 Investigation of Certain Products Containing Tirzepatide
15. Certain Products Containing Tirzepatide; Notice of Issuance of a General Exclusion Order, 90 FR 15720
16. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize — FDA